Necon (Watson Pharma, Inc.)
Welcome to the PulseAid listing for the Necon drug offered from Watson Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Watson Pharma, Inc. |
NON-PROPRIETARY NAME: | Norethindrone and Mestranol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1967-11-17 |
END MARKETING DATE: | 0000-00-00 |
Necon HUMAN PRESCRIPTION DRUG Details:
Item Description | Necon from Watson Pharma, Inc. |
LABELER NAME: | Watson Pharma, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 1967-11-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52544-245_2013cfa5-7b44-42d0-addd-4fc368d7e8d8 |
PRODUCT NDC: | 52544-245 |
APPLICATION NUMBER: | NDA016659 |